Blox Labs Inc. (“Blox” or “the Company”) (CSE:BLOX, Frankfurt:BR1B, OTC:BLLXF) wishes to announce that, further to its news release of March 1, 2019, it has obtained conditional approval from the Canadian Securities Exchange (the “CSE”) for the listing of the common shares (the “Shares”) that will result from the reverse takeover (“RTO”) of Blox by Best Cannabis Products Inc. (“BCP”). Upon completion of the RTO, Blox will issue a total of 234,800,000 Shares to the shareholders of BCP pursuant to a share exchange agreement dated February 28, 2019 with BCP and its shareholders. The resulting issuer will change its name to Sire Bioscience Inc. (“Sire”) upon completion of the RTO.

Blox has received more than the requisite 51% shareholder consent approving the RTO, and we anticipate closing the private placement financing that was announced on March 1, 2019 before the end of August 2019. Furthermore, it is expected that the listing of Sire’s Shares on the CSE will occur in September 2019 and those Shares will trade under the ticker symbol “SIRE”.


A copy of the Form 2A listing statement in connection with the RTO was prepared in accordance with the policies of the CSE and will be available on SEDAR at www.sedar.com and the CSE website prior to the commencement of trading on the CSE.

Sire’s new website, www.sirebioscience.com, is currently under construction and will be available in the near future.

About Blox Labs Inc.

As a result of the RTO, Blox will change the nature of its business from technology development to life sciences, with a focus on the cultivation, production and sale of industrial hemp. BCP has obtained its Industrial Hemp License from Health Canada under no. LIC-MAQ20YRUT8-2019. BCP is a Canadian company headquartered in Toronto, Ontario that owns a 50 acre parcel of land, inclusive of a 160,000 sq. ft. state-of-the-art greenhouse, in Leamington, Ontario – a preeminent locale for hemp and cannabis cultivation in Canada.

For additional information:

Blox Labs Inc.

Jeff Zanini

CEO

Blox Labs Inc.
E: ir@bloxlabs.ca

T: 416-262-0871

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

Click here to connect with Blox Labs Inc. (CSE:BLOX) (Frankfurt:BR1B) for an Investor Presentation.

Considering investing in blockchain?

 
Read your free 2020 blockchain outlook report!
 

Source: www.thenewswire.com

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less